Profund Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$712K Sell
1,827
-22
-1% -$9.3K 0.02% 437
2026
Q1
$875K Sell
1,849
-934
-34% -$470K 0.03% 384
2025
Q4
$1.3M Buy
2,783
+564
+25% +$262K 0.04% 289
2025
Q3
$946K Sell
2,219
-288
-11% -$112K 0.03% 343
2025
Q2
$960K Sell
2,507
-6
-0.2% -$2.16K 0.03% 312
2025
Q1
$868K Sell
2,513
-209
-8% -$67.2K 0.04% 329
2024
Q4
$817K Sell
2,722
-237
-8% -$82.8K 0.03% 337
2024
Q3
$1.2M Sell
2,959
-80
-3% -$29.3K 0.05% 283
2024
Q2
$976K Sell
3,039
-82
-3% -$26.6K 0.04% 304
2024
Q1
$1.04M Sell
3,121
-88
-3% -$26.9K 0.04% 348
2023
Q4
$869K Buy
3,209
+103
+3% +$25.5K 0.04% 358
2023
Q3
$764K Sell
3,106
-131
-4% -$35.8K 0.04% 348
2023
Q2
$982K Sell
3,237
-10
-0.3% -$2.78K 0.05% 315
2023
Q1
$856K Sell
3,247
-229
-7% -$58.2K 0.05% 340
2022
Q4
$834K Buy
3,476
+94
+3% +$21.1K 0.05% 301
2022
Q3
$622K Sell
3,382
-415
-11% -$82.7K 0.04% 335
2022
Q2
$638K Sell
3,797
-739
-16% -$159K 0.04% 365
2022
Q1
$1.14M Sell
4,536
-726
-14% -$182K 0.05% 290
2021
Q4
$1.35M Buy
5,262
+402
+8% +$98.4K 0.04% 267
2021
Q3
$1.18M Sell
4,860
-284
-6% -$69.4K 0.04% 307
2021
Q2
$1.06M Sell
5,144
-11
-0.2% -$2.24K 0.04% 343
2021
Q1
$971K Sell
5,155
-255
-5% -$45K 0.04% 322
2020
Q4
$890K Sell
5,410
-94
-2% -$13.7K 0.04% 341
2020
Q3
$686K Sell
5,504
-1,335
-20% -$165K 0.04% 368
2020
Q2
$664K Buy
6,839
+852
+14% +$88.6K 0.04% 348
2020
Q1
$538K Sell
5,987
-1,562
-21% -$202K 0.04% 343
2019
Q4
$1.12M Buy
7,549
+639
+9% +$85.8K 0.05% 324
2019
Q3
$832K Sell
6,910
-970
-12% -$125K 0.04% 381
2019
Q2
$1.06M Sell
7,880
-2,053
-21% -$260K 0.05% 346
2019
Q1
$1.29M Buy
9,933
+758
+8% +$102K 0.06% 278
2018
Q4
$1.14M Sell
9,175
-1,768
-16% -$237K 0.07% 256
2018
Q3
$1.52M Buy
10,943
+2,548
+30% +$317K 0.06% 265
2018
Q2
$861K Sell
8,395
-874
-9% -$88.4K 0.03% 438
2018
Q1
$899K Sell
9,269
-808
-8% -$78.4K 0.04% 470
2017
Q4
$885K Sell
10,077
-3,295
-25% -$265K 0.03% 509
2017
Q3
$1.06M Buy
13,372
+1,095
+9% +$88.1K 0.04% 394
2017
Q2
$1.07M Buy
12,277
+612
+5% +$51.8K 0.05% 357
2017
Q1
$1.04M Buy
11,665
+934
+9% +$77.9K 0.05% 421
2016
Q4
$794K Sell
10,731
-819
-7% -$61.3K 0.04% 579
2016
Q3
$874K Sell
11,550
-963
-8% -$73.7K 0.04% 446
2016
Q2
$964K Sell
12,513
-1,798
-13% -$142K 0.05% 417
2016
Q1
$1.12M Sell
14,311
-2,590
-15% -$181K 0.06% 309
2015
Q4
$1.14M Sell
16,901
-3,220
-16% -$225K 0.05% 311
2015
Q3
$1.56M Sell
20,121
-3,736
-16% -$331K 0.09% 183
2015
Q2
$2.16M Buy
23,857
+1,383
+6% +$111K 0.09% 165
2015
Q1
$1.69M Buy
22,474
+6,886
+44% +$495K 0.07% 264
2014
Q4
$1.14M Buy
15,588
+2,646
+20% +$186K 0.05% 383
2014
Q3
$913K Buy
12,942
+1,808
+16% +$119K 0.04% 418
2014
Q2
$628K Sell
11,134
-2,736
-20% -$144K 0.03% 756
2014
Q1
$728K Buy
13,870
+3,196
+30% +$159K 0.03% 653
2013
Q4
$509K Buy
10,674
+1,650
+18% +$76.3K 0.02% 1016
2013
Q3
$386K Buy
9,024
+954
+12% +$37.3K 0.02% 1113
2013
Q2
$291K Buy
+8,070
New +$312K 0.02% 999

Other funds holding HCA

Profund Advisors's HCA Position: Q2 2026 in Review

Profund Advisors reduced its HCA Healthcare (HCA) stake by 1.2% in Q2 2026, selling an estimated $9.3K and leaving 1,827 shares worth $712K. The position accounts for 0.02% of the portfolio, ranked #437.

Profund Advisors first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.16M in Q2 2015. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Profund Advisors held 1,827 shares of HCA Healthcare worth $712K as of Q2 2026.
  • Profund Advisors sold 22 HCA Healthcare shares in Q2 2026, an estimated $9.3K.
  • HCA Healthcare made up 0.02% of Profund Advisors's portfolio in Q2 2026, its #437 holding.
  • Profund Advisors first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
  • Profund Advisors's HCA Healthcare position peaked at $2.16M in Q2 2015.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.